Public, Private Entities Continue Efforts To Develop Ebola Vaccines, Therapies

Media outlets report on various aspects of efforts to develop a vaccine for Ebola and produce more doses of experimental drugs to treat the disease.

ABC News: Will There Be an Ebola Vaccine Soon? (Besser, 10/17).
Agence France-Presse: Experimental Ebola vaccine expected in Geneva Tuesday: hospital (10/19).
Agence France-Presse: Ebola vaccine not before late 2016: GSK researcher (10/17).
The Guardian: Progress towards Ebola vaccine would have been faster had bioterrorism research been completed (Jones/Boseley, 10/17).
The Hill: Budget cuts not to blame for lack Ebola vaccine, Fauci says (Hattem, 10/19).
Reuters: GSK says Ebola vaccine development progressing at “unprecedented rate” (10/19).
Reuters: U.S. requests production plans for Ebola drug ZMapp (Begley, 10/17).
Wall Street Journal: Ebola Drug Race Ramps Up in Earnest (Loftus/McKay, 10/17).
Wall Street Journal: Why the Work of Dr. Nancy J. Sullivan Could Be Key to a Potential Ebola Vaccine (Burton, 10/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.